## Mphasis Ltd. Stock Analysis

**1. Company Overview:**

Mphasis Ltd. is a global IT solutions provider specializing in cloud and cognitive services.  Its business model centers around helping enterprises transform their businesses using next-generation technology.  The company holds a significant position within the Indian IT sector, being a constituent of several major indices including the Nifty 500, indicating its size and market relevance.  While specific achievements aren't detailed in the provided data, its inclusion in numerous indices suggests a track record of success and market recognition.

**2. Key Financial Metrics:**

* **Market Cap:** ₹ 55,960 Cr.
* **Current Price:** ₹ 2,951
* **High/Low (52-week):** ₹ 3,240 / ₹ 2,180
* **P/E Ratio:** 35.1
* **Book Value:** ₹ 458
* **Dividend Yield:** 1.86%
* **ROCE:** 24.0%
* **ROE:** 18.4%
* **Face Value:** ₹ 10.0

**3. Strengths and Weaknesses:**

**Strengths:**

* **Healthy ROCE and ROE:**  Indicating efficient capital utilization and profitability.
* **Consistent Dividend Payout:**  The provided "Other Insights" mention a healthy dividend payout of 61.6%, suggesting a commitment to returning value to shareholders.  This needs further verification with detailed financial statements.
* **Improved Working Capital:**  Reduction in working capital days from 23.0 to 15.5 days points towards improved operational efficiency.  This also needs further verification.

**Weaknesses:**

* **High P/E Ratio:** A P/E ratio of 35.1 suggests the stock might be relatively expensive compared to its earnings, especially considering the slowing growth.
* **Declining Sales and Profit Growth:**  The provided growth rates show a significant deceleration in sales and profit growth, particularly in the TTM period (-1% profit growth). This is a major concern.
* **Decreasing Promoter Holding:** A 15.6% decrease in promoter holding over three years raises concerns about potential future management changes or lack of confidence from insiders.

**4. Performance Trends:**

The provided data lacks detailed quarterly and annual financial statements (Sales & Margin, Profit & Loss, Balance Sheet, Cash Flow).  A thorough analysis of these statements is crucial for a complete understanding of performance trends.  Without this data, a comprehensive assessment of financial health and operational efficiency is impossible.

**5. Growth Metrics:**

* **Sales CAGR (10Y/5Y/3Y/TTM):** 18%/11%/11%/2% - Shows a significant slowdown in sales growth.
* **Profit CAGR (10Y/5Y/3Y/TTM):** 17%/8%/8%/-1% -  Similar deceleration in profit growth, with negative growth in the TTM period.
* **Stock Price CAGR (10Y/5Y/3Y/1Y):** 23%/27%/-2%/8% -  While past performance has been strong, recent performance has been weak.
* **ROE (10Y/5Y/3Y/LY):** 18%/20%/20%/18% - Relatively stable ROE, but needs context from detailed financial statements.

**6. Comparison to Benchmarks:**

Mphasis's P/E ratio (35.1) is slightly above the median P/E of its peers (35.09).  However,  a more in-depth comparison requires analyzing other metrics like ROCE, revenue growth, and profitability margins against its peers.  Mphasis's ROCE (24%) is lower than the median of its peers (29.6%).  This comparison highlights that while Mphasis's valuation is comparable to its peers, its operational efficiency is relatively lower.

**7. Stock Valuation:**

Based on the limited data, Mphasis appears to be potentially overvalued. The high P/E ratio of 35.1, coupled with decelerating growth rates, suggests that the current market price may not fully reflect the company's future earnings potential.  A more detailed analysis incorporating discounted cash flow (DCF) or other valuation models, along with a thorough review of the financial statements, is necessary for a definitive valuation.

**8. Recommendations and Confidence Levels:**

Due to the lack of complete financial statement data, assigning precise recommendations with high confidence is not possible.  The analysis is severely limited without access to the detailed financial data.  Therefore, I cannot provide specific short, medium, or long-term recommendations at this time.  The confidence level for any recommendation would be **Low**.  Further analysis with complete financial data is required to improve the confidence level.

**9. Final Verdict:**

Mphasis shows signs of slowing growth and a potentially overvalued stock price based on the limited data provided.  The high P/E ratio and declining growth rates are significant concerns.  However, a comprehensive analysis is impossible without access to the complete financial statements.  Investors should wait for a more detailed analysis before making any investment decisions.  The current analysis highlights the need for a deeper dive into the company's financials to assess its true value and future prospects.  Until complete financial data is available, a neutral stance is recommended.
